Tin tức & Cập nhật
Xem bài viết Da liễu
Xem
Chỉ hiển thị Multimedia

Dupilumab eases itch, disease activity in chronic spontaneous urticaria
16 Mar 2025
bởiStephen Padilla
Patients with chronic spontaneous urticaria (CSA) who has uncontrolled disease despite treatment with H1-antihistamines may benefit from using dupilumab, which has been shown to reduce itch and urticaria activity in two phase III trials.
Dupilumab eases itch, disease activity in chronic spontaneous urticaria
16 Mar 2025
Pandemic babies have a 46 percent higher risk of atopic diseases
05 Feb 2025
bởiKanas Chan
The incidence of atopic diseases in infants born in Hong Kong has increased by 46 percent during the COVID-19 pandemic, potentially linked to altered neonatal microbiome diversity resulting from vigorous disinfection. SIM03 and SIM05, symbiotic formulae developed with the aid of artificial intelligence (AI), are shown to improve eczema severity and quality of life (QoL) in children and adults, respectively, by modulating gut microbiota.







